Characterization of Anti-idiotypic Antibodies for High Performance in Bioanalytical Assays

Presented at European Bioanalysis Forum 9th Open Meeting, Barcelona 16-18 November 2016

This poster demonstrates how Bio-Rad applies industry recommended standards to characterize recombinant monoclonal anti-idiotypic antibodies that are manufactured and qualified for use in pharmacokinetic and anti-drug antibody assays.

  • Quality control to ensure batch-to batch consistency
  • Purity assessment of Fab antibodies and full immunoglobulins
  • Accelerated stability and freeze-thaw testing
  • Affinity determination

Read more about using HuCAL® technology to generate antibodies to biosimilars and novel biotherapeutics for the development of bioanalytical assays.